iSpecimen Inc. (ISPC) Stock Competitors & Peer Comparison
See (ISPC) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ISPC | $3.16 | -4.82% | 438.8K | -0.01 | -$329.05 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.74% |
| TMO | $492.51 | +1.09% | 183B | 27.06 | $18.20 | +0.36% |
| DHR | $182.67 | +1.13% | 129.3B | 35.34 | $5.17 | +0.74% |
| IDXX | $563.53 | -0.79% | 44.5B | 41.44 | $13.60 | N/A |
| A | $135.53 | +0.11% | 38.3B | 27.22 | $4.98 | +0.55% |
| NTRA | $223.37 | +4.41% | 32B | -137.04 | -$1.63 | N/A |
| IQV | $182.21 | +0.62% | 30.4B | 22.64 | $8.05 | N/A |
| WAT | $383.57 | +4.61% | 25B | 48.86 | $7.86 | N/A |
| ILMN | $162.96 | +2.68% | 24.7B | 29.63 | $5.50 | N/A |
Stock Comparison
ISPC vs DHR-PB Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, ISPC is priced at $3.16, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, ISPC's ROE is -5.85%, compared to DHR-PB's ROE of +0.07%. Regarding short-term risk, ISPC is more volatile compared to DHR-PB. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check DHR-PB's competition here
ISPC vs TMO Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, TMO has a market cap of 183B. Regarding current trading prices, ISPC is priced at $3.16, while TMO trades at $492.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas TMO's P/E ratio is 27.06. In terms of profitability, ISPC's ROE is -5.85%, compared to TMO's ROE of +0.13%. Regarding short-term risk, ISPC is more volatile compared to TMO. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check TMO's competition here
ISPC vs DHR Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, DHR has a market cap of 129.3B. Regarding current trading prices, ISPC is priced at $3.16, while DHR trades at $182.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas DHR's P/E ratio is 35.34. In terms of profitability, ISPC's ROE is -5.85%, compared to DHR's ROE of +0.07%. Regarding short-term risk, ISPC is more volatile compared to DHR. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check DHR's competition here
ISPC vs IDXX Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, IDXX has a market cap of 44.5B. Regarding current trading prices, ISPC is priced at $3.16, while IDXX trades at $563.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas IDXX's P/E ratio is 41.44. In terms of profitability, ISPC's ROE is -5.85%, compared to IDXX's ROE of +0.71%. Regarding short-term risk, ISPC is more volatile compared to IDXX. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check IDXX's competition here
ISPC vs A Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, A has a market cap of 38.3B. Regarding current trading prices, ISPC is priced at $3.16, while A trades at $135.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas A's P/E ratio is 27.22. In terms of profitability, ISPC's ROE is -5.85%, compared to A's ROE of +0.21%. Regarding short-term risk, ISPC is more volatile compared to A. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check A's competition here
ISPC vs NTRA Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, NTRA has a market cap of 32B. Regarding current trading prices, ISPC is priced at $3.16, while NTRA trades at $223.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas NTRA's P/E ratio is -137.04. In terms of profitability, ISPC's ROE is -5.85%, compared to NTRA's ROE of -0.15%. Regarding short-term risk, ISPC is less volatile compared to NTRA. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check NTRA's competition here
ISPC vs IQV Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, IQV has a market cap of 30.4B. Regarding current trading prices, ISPC is priced at $3.16, while IQV trades at $182.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas IQV's P/E ratio is 22.64. In terms of profitability, ISPC's ROE is -5.85%, compared to IQV's ROE of +0.22%. Regarding short-term risk, ISPC is more volatile compared to IQV. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check IQV's competition here
ISPC vs WAT Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, WAT has a market cap of 25B. Regarding current trading prices, ISPC is priced at $3.16, while WAT trades at $383.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas WAT's P/E ratio is 48.86. In terms of profitability, ISPC's ROE is -5.85%, compared to WAT's ROE of +0.08%. Regarding short-term risk, ISPC is more volatile compared to WAT. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check WAT's competition here
ISPC vs ILMN Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, ILMN has a market cap of 24.7B. Regarding current trading prices, ISPC is priced at $3.16, while ILMN trades at $162.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas ILMN's P/E ratio is 29.63. In terms of profitability, ISPC's ROE is -5.85%, compared to ILMN's ROE of +0.34%. Regarding short-term risk, ISPC is more volatile compared to ILMN. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check ILMN's competition here
ISPC vs MTD Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, MTD has a market cap of 23.9B. Regarding current trading prices, ISPC is priced at $3.16, while MTD trades at $1,180.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas MTD's P/E ratio is 27.78. In terms of profitability, ISPC's ROE is -5.85%, compared to MTD's ROE of -6.10%. Regarding short-term risk, ISPC is more volatile compared to MTD. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check MTD's competition here
ISPC vs DGX Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, DGX has a market cap of 21.6B. Regarding current trading prices, ISPC is priced at $3.16, while DGX trades at $194.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas DGX's P/E ratio is 21.56. In terms of profitability, ISPC's ROE is -5.85%, compared to DGX's ROE of +0.14%. Regarding short-term risk, ISPC is more volatile compared to DGX. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check DGX's competition here
ISPC vs LH Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, LH has a market cap of 21.3B. Regarding current trading prices, ISPC is priced at $3.16, while LH trades at $260.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas LH's P/E ratio is 23.04. In terms of profitability, ISPC's ROE is -5.85%, compared to LH's ROE of +0.11%. Regarding short-term risk, ISPC is more volatile compared to LH. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check LH's competition here
ISPC vs EXAS Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, ISPC is priced at $3.16, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas EXAS's P/E ratio is -95.37. In terms of profitability, ISPC's ROE is -5.85%, compared to EXAS's ROE of -0.09%. Regarding short-term risk, ISPC is more volatile compared to EXAS. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check EXAS's competition here
ISPC vs GH Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, GH has a market cap of 17.2B. Regarding current trading prices, ISPC is priced at $3.16, while GH trades at $129.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas GH's P/E ratio is -38.28. In terms of profitability, ISPC's ROE is -5.85%, compared to GH's ROE of +1.84%. Regarding short-term risk, ISPC is more volatile compared to GH. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check GH's competition here
ISPC vs PKI Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, ISPC is priced at $3.16, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas PKI's P/E ratio is 41.45. In terms of profitability, ISPC's ROE is -5.85%, compared to PKI's ROE of +0.03%. Regarding short-term risk, ISPC is more volatile compared to PKI. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check PKI's competition here
ISPC vs MEDP Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, MEDP has a market cap of 12.8B. Regarding current trading prices, ISPC is priced at $3.16, while MEDP trades at $447.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas MEDP's P/E ratio is 28.17. In terms of profitability, ISPC's ROE is -5.85%, compared to MEDP's ROE of +1.21%. Regarding short-term risk, ISPC is more volatile compared to MEDP. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check MEDP's competition here
ISPC vs RVTY Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, RVTY has a market cap of 11.7B. Regarding current trading prices, ISPC is priced at $3.16, while RVTY trades at $104.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas RVTY's P/E ratio is 50.28. In terms of profitability, ISPC's ROE is -5.85%, compared to RVTY's ROE of +0.03%. Regarding short-term risk, ISPC is more volatile compared to RVTY. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check RVTY's competition here
ISPC vs ICLR Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, ICLR has a market cap of 10.4B. Regarding current trading prices, ISPC is priced at $3.16, while ICLR trades at $136.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas ICLR's P/E ratio is 46.92. In terms of profitability, ISPC's ROE is -5.85%, compared to ICLR's ROE of +0.02%. Regarding short-term risk, ISPC is more volatile compared to ICLR. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check ICLR's competition here
ISPC vs CRL Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, CRL has a market cap of 8.7B. Regarding current trading prices, ISPC is priced at $3.16, while CRL trades at $180.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas CRL's P/E ratio is -48.58. In terms of profitability, ISPC's ROE is -5.85%, compared to CRL's ROE of -0.06%. Regarding short-term risk, ISPC is more volatile compared to CRL. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check CRL's competition here
ISPC vs QGEN Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, QGEN has a market cap of 7.5B. Regarding current trading prices, ISPC is priced at $3.16, while QGEN trades at $36.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas QGEN's P/E ratio is 18.68. In terms of profitability, ISPC's ROE is -5.85%, compared to QGEN's ROE of +0.11%. Regarding short-term risk, ISPC is more volatile compared to QGEN. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check QGEN's competition here
ISPC vs BLLN Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, BLLN has a market cap of 4.5B. Regarding current trading prices, ISPC is priced at $3.16, while BLLN trades at $98.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas BLLN's P/E ratio is 182.85. In terms of profitability, ISPC's ROE is -5.85%, compared to BLLN's ROE of +0.08%. Regarding short-term risk, ISPC is more volatile compared to BLLN. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check BLLN's competition here
ISPC vs SHC Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, SHC has a market cap of 4.5B. Regarding current trading prices, ISPC is priced at $3.16, while SHC trades at $15.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas SHC's P/E ratio is 38.15. In terms of profitability, ISPC's ROE is -5.85%, compared to SHC's ROE of +0.21%. Regarding short-term risk, ISPC is more volatile compared to SHC. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check SHC's competition here
ISPC vs SYNH Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, ISPC is priced at $3.16, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas SYNH's P/E ratio is 61.40. In terms of profitability, ISPC's ROE is -5.85%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, ISPC is more volatile compared to SYNH. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check SYNH's competition here
ISPC vs RDNT Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, RDNT has a market cap of 4.4B. Regarding current trading prices, ISPC is priced at $3.16, while RDNT trades at $55.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas RDNT's P/E ratio is -326.65. In terms of profitability, ISPC's ROE is -5.85%, compared to RDNT's ROE of -0.01%. Regarding short-term risk, ISPC is more volatile compared to RDNT. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check RDNT's competition here
ISPC vs TWST Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, TWST has a market cap of 4.2B. Regarding current trading prices, ISPC is priced at $3.16, while TWST trades at $66.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas TWST's P/E ratio is -50.66. In terms of profitability, ISPC's ROE is -5.85%, compared to TWST's ROE of -0.17%. Regarding short-term risk, ISPC is more volatile compared to TWST. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check TWST's competition here
ISPC vs OLK Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, ISPC is priced at $3.16, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas OLK's P/E ratio is -96.59. In terms of profitability, ISPC's ROE is -5.85%, compared to OLK's ROE of -0.07%. Regarding short-term risk, ISPC is more volatile compared to OLK. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check OLK's competition here
ISPC vs GRAL Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, GRAL has a market cap of 3.1B. Regarding current trading prices, ISPC is priced at $3.16, while GRAL trades at $71.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas GRAL's P/E ratio is -6.96. In terms of profitability, ISPC's ROE is -5.85%, compared to GRAL's ROE of -0.16%. Regarding short-term risk, ISPC is more volatile compared to GRAL. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check GRAL's competition here
ISPC vs NEOG Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, NEOG has a market cap of 2B. Regarding current trading prices, ISPC is priced at $3.16, while NEOG trades at $8.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas NEOG's P/E ratio is -3.20. In terms of profitability, ISPC's ROE is -5.85%, compared to NEOG's ROE of -0.29%. Regarding short-term risk, ISPC is more volatile compared to NEOG. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check NEOG's competition here
ISPC vs CDNA Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, CDNA has a market cap of 1.2B. Regarding current trading prices, ISPC is priced at $3.16, while CDNA trades at $22.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas CDNA's P/E ratio is -142.62. In terms of profitability, ISPC's ROE is -5.85%, compared to CDNA's ROE of -0.03%. Regarding short-term risk, ISPC is more volatile compared to CDNA. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check CDNA's competition here
ISPC vs PSNL Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, PSNL has a market cap of 1B. Regarding current trading prices, ISPC is priced at $3.16, while PSNL trades at $11.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas PSNL's P/E ratio is -11.18. In terms of profitability, ISPC's ROE is -5.85%, compared to PSNL's ROE of -0.44%. Regarding short-term risk, ISPC is less volatile compared to PSNL. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check PSNL's competition here
ISPC vs CSTL Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, CSTL has a market cap of 639.4M. Regarding current trading prices, ISPC is priced at $3.16, while CSTL trades at $21.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas CSTL's P/E ratio is -50.19. In terms of profitability, ISPC's ROE is -5.85%, compared to CSTL's ROE of -0.03%. Regarding short-term risk, ISPC is more volatile compared to CSTL. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check CSTL's competition here
ISPC vs GRALV Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, ISPC is priced at $3.16, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas GRALV's P/E ratio is N/A. In terms of profitability, ISPC's ROE is -5.85%, compared to GRALV's ROE of N/A. Regarding short-term risk, ISPC is less volatile compared to GRALV. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check GRALV's competition here
ISPC vs FLGT Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, FLGT has a market cap of 515.2M. Regarding current trading prices, ISPC is priced at $3.16, while FLGT trades at $18.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas FLGT's P/E ratio is -7.56. In terms of profitability, ISPC's ROE is -5.85%, compared to FLGT's ROE of -0.07%. Regarding short-term risk, ISPC is more volatile compared to FLGT. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check FLGT's competition here
ISPC vs CO Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, ISPC is priced at $3.16, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas CO's P/E ratio is 5.06. In terms of profitability, ISPC's ROE is -5.85%, compared to CO's ROE of +0.11%. Regarding short-term risk, ISPC is less volatile compared to CO. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check CO's competition here
ISPC vs MYGN Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, MYGN has a market cap of 375M. Regarding current trading prices, ISPC is priced at $3.16, while MYGN trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas MYGN's P/E ratio is -0.92. In terms of profitability, ISPC's ROE is -5.85%, compared to MYGN's ROE of -1.09%. Regarding short-term risk, ISPC is less volatile compared to MYGN. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check MYGN's competition here
ISPC vs PRE Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, PRE has a market cap of 358.7M. Regarding current trading prices, ISPC is priced at $3.16, while PRE trades at $21.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas PRE's P/E ratio is -8.58. In terms of profitability, ISPC's ROE is -5.85%, compared to PRE's ROE of -0.36%. Regarding short-term risk, ISPC is less volatile compared to PRE. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check PRE's competition here
ISPC vs FLDM Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, ISPC is priced at $3.16, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas FLDM's P/E ratio is -4.74. In terms of profitability, ISPC's ROE is -5.85%, compared to FLDM's ROE of +0.17%. Regarding short-term risk, ISPC is less volatile compared to FLDM. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check FLDM's competition here
ISPC vs NEO Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, NEO has a market cap of 274M. Regarding current trading prices, ISPC is priced at $3.16, while NEO trades at $10.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas NEO's P/E ratio is -13.66. In terms of profitability, ISPC's ROE is -5.85%, compared to NEO's ROE of -0.12%. Regarding short-term risk, ISPC is more volatile compared to NEO. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check NEO's competition here
ISPC vs OPGN Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, OPGN has a market cap of 242.7M. Regarding current trading prices, ISPC is priced at $3.16, while OPGN trades at $23.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas OPGN's P/E ratio is 132.83. In terms of profitability, ISPC's ROE is -5.85%, compared to OPGN's ROE of +1.58%. Regarding short-term risk, ISPC is more volatile compared to OPGN. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check OPGN's competition here
ISPC vs IMDX Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, IMDX has a market cap of 166.7M. Regarding current trading prices, ISPC is priced at $3.16, while IMDX trades at $6.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas IMDX's P/E ratio is -4.11. In terms of profitability, ISPC's ROE is -5.85%, compared to IMDX's ROE of +3.81%. Regarding short-term risk, ISPC is less volatile compared to IMDX. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check IMDX's competition here
ISPC vs BDSX Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, BDSX has a market cap of 132.8M. Regarding current trading prices, ISPC is priced at $3.16, while BDSX trades at $16.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas BDSX's P/E ratio is -4.12. In terms of profitability, ISPC's ROE is -5.85%, compared to BDSX's ROE of -21.01%. Regarding short-term risk, ISPC is less volatile compared to BDSX. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check BDSX's competition here
ISPC vs GTH Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, ISPC is priced at $3.16, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas GTH's P/E ratio is -1.11. In terms of profitability, ISPC's ROE is -5.85%, compared to GTH's ROE of -1.01%. Regarding short-term risk, ISPC is more volatile compared to GTH. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check GTH's competition here
ISPC vs XGN Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, XGN has a market cap of 120.3M. Regarding current trading prices, ISPC is priced at $3.16, while XGN trades at $4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas XGN's P/E ratio is -5.53. In terms of profitability, ISPC's ROE is -5.85%, compared to XGN's ROE of -1.14%. Regarding short-term risk, ISPC is more volatile compared to XGN. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check XGN's competition here
ISPC vs ATLN Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, ATLN has a market cap of 119M. Regarding current trading prices, ISPC is priced at $3.16, while ATLN trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas ATLN's P/E ratio is -1.39. In terms of profitability, ISPC's ROE is -5.85%, compared to ATLN's ROE of +2.74%. Regarding short-term risk, ISPC is less volatile compared to ATLN. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check ATLN's competition here
ISPC vs GENE Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, ISPC is priced at $3.16, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas GENE's P/E ratio is -38.25. In terms of profitability, ISPC's ROE is -5.85%, compared to GENE's ROE of -1.85%. Regarding short-term risk, ISPC is more volatile compared to GENE. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check GENE's competition here
ISPC vs STIM Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, STIM has a market cap of 107.2M. Regarding current trading prices, ISPC is priced at $3.16, while STIM trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas STIM's P/E ratio is -2.85. In terms of profitability, ISPC's ROE is -5.85%, compared to STIM's ROE of -1.65%. Regarding short-term risk, ISPC is less volatile compared to STIM. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check STIM's competition here
ISPC vs SERA Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, SERA has a market cap of 82.5M. Regarding current trading prices, ISPC is priced at $3.16, while SERA trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas SERA's P/E ratio is -3.37. In terms of profitability, ISPC's ROE is -5.85%, compared to SERA's ROE of -0.41%. Regarding short-term risk, ISPC is less volatile compared to SERA. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check SERA's competition here
ISPC vs DRIO Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, DRIO has a market cap of 56.7M. Regarding current trading prices, ISPC is priced at $3.16, while DRIO trades at $7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas DRIO's P/E ratio is -0.91. In terms of profitability, ISPC's ROE is -5.85%, compared to DRIO's ROE of +0.93%. Regarding short-term risk, ISPC is more volatile compared to DRIO. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check DRIO's competition here
ISPC vs STRR Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, STRR has a market cap of 43.1M. Regarding current trading prices, ISPC is priced at $3.16, while STRR trades at $11.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas STRR's P/E ratio is -4.66. In terms of profitability, ISPC's ROE is -5.85%, compared to STRR's ROE of -0.14%. Regarding short-term risk, ISPC is more volatile compared to STRR. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check STRR's competition here
ISPC vs PRPO Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, PRPO has a market cap of 40.8M. Regarding current trading prices, ISPC is priced at $3.16, while PRPO trades at $22.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas PRPO's P/E ratio is -50.67. In terms of profitability, ISPC's ROE is -5.85%, compared to PRPO's ROE of -0.07%. Regarding short-term risk, ISPC is more volatile compared to PRPO. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check PRPO's competition here
ISPC vs MDXH Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, MDXH has a market cap of 38M. Regarding current trading prices, ISPC is priced at $3.16, while MDXH trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas MDXH's P/E ratio is -1.14. In terms of profitability, ISPC's ROE is -5.85%, compared to MDXH's ROE of +4.03%. Regarding short-term risk, ISPC is more volatile compared to MDXH. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check MDXH's competition here
ISPC vs STRRP Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, STRRP has a market cap of 33.5M. Regarding current trading prices, ISPC is priced at $3.16, while STRRP trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas STRRP's P/E ratio is -4.95. In terms of profitability, ISPC's ROE is -5.85%, compared to STRRP's ROE of -0.14%. Regarding short-term risk, ISPC is more volatile compared to STRRP. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check STRRP's competition here
ISPC vs QUCY Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, QUCY has a market cap of 31.5M. Regarding current trading prices, ISPC is priced at $3.16, while QUCY trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas QUCY's P/E ratio is -0.11. In terms of profitability, ISPC's ROE is -5.85%, compared to QUCY's ROE of -2.44%. Regarding short-term risk, ISPC is less volatile compared to QUCY. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check QUCY's competition here
ISPC vs AKU Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, ISPC is priced at $3.16, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas AKU's P/E ratio is -0.13. In terms of profitability, ISPC's ROE is -5.85%, compared to AKU's ROE of -5.32%. Regarding short-term risk, ISPC is less volatile compared to AKU. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check AKU's competition here
ISPC vs CEMI Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, ISPC is priced at $3.16, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas CEMI's P/E ratio is -0.63. In terms of profitability, ISPC's ROE is -5.85%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, ISPC is more volatile compared to CEMI. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check CEMI's competition here
ISPC vs ENZ Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, ISPC is priced at $3.16, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas ENZ's P/E ratio is -2.24. In terms of profitability, ISPC's ROE is -5.85%, compared to ENZ's ROE of -0.10%. Regarding short-term risk, ISPC is less volatile compared to ENZ. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check ENZ's competition here
ISPC vs PMD Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, ISPC is priced at $3.16, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas PMD's P/E ratio is -5.24. In terms of profitability, ISPC's ROE is -5.85%, compared to PMD's ROE of -0.32%. Regarding short-term risk, ISPC is more volatile compared to PMD. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check PMD's competition here
ISPC vs ME Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, ISPC is priced at $3.16, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas ME's P/E ratio is -0.03. In terms of profitability, ISPC's ROE is -5.85%, compared to ME's ROE of -7.71%. Regarding short-term risk, ISPC is more volatile compared to ME. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check ME's competition here
ISPC vs MYNZ Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, ISPC is priced at $3.16, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas MYNZ's P/E ratio is -0.68. In terms of profitability, ISPC's ROE is -5.85%, compared to MYNZ's ROE of -10.25%. Regarding short-term risk, ISPC is less volatile compared to MYNZ. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check MYNZ's competition here
ISPC vs VNRX Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, VNRX has a market cap of 14.3M. Regarding current trading prices, ISPC is priced at $3.16, while VNRX trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas VNRX's P/E ratio is -0.63. In terms of profitability, ISPC's ROE is -5.85%, compared to VNRX's ROE of +0.74%. Regarding short-term risk, ISPC is less volatile compared to VNRX. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check VNRX's competition here
ISPC vs CHEK Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, ISPC is priced at $3.16, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas CHEK's P/E ratio is -0.43. In terms of profitability, ISPC's ROE is -5.85%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, ISPC is more volatile compared to CHEK. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check CHEK's competition here
ISPC vs BNR Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, BNR has a market cap of 10.2M. Regarding current trading prices, ISPC is priced at $3.16, while BNR trades at $9.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas BNR's P/E ratio is -12.52. In terms of profitability, ISPC's ROE is -5.85%, compared to BNR's ROE of -0.10%. Regarding short-term risk, ISPC is less volatile compared to BNR. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check BNR's competition here
ISPC vs NOTV Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, NOTV has a market cap of 10M. Regarding current trading prices, ISPC is priced at $3.16, while NOTV trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas NOTV's P/E ratio is -0.12. In terms of profitability, ISPC's ROE is -5.85%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, ISPC is less volatile compared to NOTV. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check NOTV's competition here
ISPC vs CNTG Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, ISPC is priced at $3.16, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas CNTG's P/E ratio is -0.23. In terms of profitability, ISPC's ROE is -5.85%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, ISPC is more volatile compared to CNTG. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check CNTG's competition here
ISPC vs MBAI Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, MBAI has a market cap of 9.4M. Regarding current trading prices, ISPC is priced at $3.16, while MBAI trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas MBAI's P/E ratio is 2.42. In terms of profitability, ISPC's ROE is -5.85%, compared to MBAI's ROE of +4.17%. Regarding short-term risk, ISPC is more volatile compared to MBAI. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check MBAI's competition here
ISPC vs BIAF Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, BIAF has a market cap of 7.6M. Regarding current trading prices, ISPC is priced at $3.16, while BIAF trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas BIAF's P/E ratio is -0.36. In terms of profitability, ISPC's ROE is -5.85%, compared to BIAF's ROE of -3.59%. Regarding short-term risk, ISPC is more volatile compared to BIAF. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check BIAF's competition here
ISPC vs TRIB Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, TRIB has a market cap of 7.3M. Regarding current trading prices, ISPC is priced at $3.16, while TRIB trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas TRIB's P/E ratio is -0.35. In terms of profitability, ISPC's ROE is -5.85%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, ISPC is less volatile compared to TRIB. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check TRIB's competition here
ISPC vs APDN Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, ISPC is priced at $3.16, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas APDN's P/E ratio is -0.10. In terms of profitability, ISPC's ROE is -5.85%, compared to APDN's ROE of -6.53%. Regarding short-term risk, ISPC is less volatile compared to APDN. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check APDN's competition here
ISPC vs NVTA Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, ISPC is priced at $3.16, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas NVTA's P/E ratio is -0.00. In terms of profitability, ISPC's ROE is -5.85%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, ISPC is less volatile compared to NVTA. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check NVTA's competition here
ISPC vs ADVB Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, ADVB has a market cap of 5.4M. Regarding current trading prices, ISPC is priced at $3.16, while ADVB trades at $5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas ADVB's P/E ratio is 1.25. In terms of profitability, ISPC's ROE is -5.85%, compared to ADVB's ROE of -0.20%. Regarding short-term risk, ISPC is less volatile compared to ADVB. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check ADVB's competition here
ISPC vs LMDX Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, ISPC is priced at $3.16, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas LMDX's P/E ratio is -0.01. In terms of profitability, ISPC's ROE is -5.85%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, ISPC is less volatile compared to LMDX. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check LMDX's competition here
ISPC vs LMDXW Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, ISPC is priced at $3.16, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, ISPC's ROE is -5.85%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, ISPC is less volatile compared to LMDXW. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check LMDXW's competition here
ISPC vs BGLC Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, BGLC has a market cap of 4.7M. Regarding current trading prices, ISPC is priced at $3.16, while BGLC trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas BGLC's P/E ratio is -1.57. In terms of profitability, ISPC's ROE is -5.85%, compared to BGLC's ROE of -0.37%. Regarding short-term risk, ISPC is less volatile compared to BGLC. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check BGLC's competition here
ISPC vs NDRA Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, NDRA has a market cap of 4.1M. Regarding current trading prices, ISPC is priced at $3.16, while NDRA trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas NDRA's P/E ratio is -0.67. In terms of profitability, ISPC's ROE is -5.85%, compared to NDRA's ROE of -5.13%. Regarding short-term risk, ISPC is less volatile compared to NDRA. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check NDRA's competition here
ISPC vs BNGO Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, BNGO has a market cap of 4.1M. Regarding current trading prices, ISPC is priced at $3.16, while BNGO trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas BNGO's P/E ratio is -0.28. In terms of profitability, ISPC's ROE is -5.85%, compared to BNGO's ROE of -0.71%. Regarding short-term risk, ISPC is more volatile compared to BNGO. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check BNGO's competition here
ISPC vs DMTK Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, ISPC is priced at $3.16, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas DMTK's P/E ratio is -0.04. In terms of profitability, ISPC's ROE is -5.85%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, ISPC is less volatile compared to DMTK. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check DMTK's competition here
ISPC vs SQL Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, ISPC is priced at $3.16, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas SQL's P/E ratio is -0.40. In terms of profitability, ISPC's ROE is -5.85%, compared to SQL's ROE of +2.74%. Regarding short-term risk, ISPC is less volatile compared to SQL. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check SQL's competition here
ISPC vs AWH Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, ISPC is priced at $3.16, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas AWH's P/E ratio is -0.09. In terms of profitability, ISPC's ROE is -5.85%, compared to AWH's ROE of +2.03%. Regarding short-term risk, ISPC is more volatile compared to AWH. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check AWH's competition here
ISPC vs INBS Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, INBS has a market cap of 1.7M. Regarding current trading prices, ISPC is priced at $3.16, while INBS trades at $2.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas INBS's P/E ratio is -0.22. In terms of profitability, ISPC's ROE is -5.85%, compared to INBS's ROE of -1.74%. Regarding short-term risk, ISPC is less volatile compared to INBS. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check INBS's competition here
ISPC vs HTGM Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, ISPC is priced at $3.16, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas HTGM's P/E ratio is -0.03. In terms of profitability, ISPC's ROE is -5.85%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, ISPC is more volatile compared to HTGM. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check HTGM's competition here
ISPC vs BIAFW Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, BIAFW has a market cap of 764.5K. Regarding current trading prices, ISPC is priced at $3.16, while BIAFW trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas BIAFW's P/E ratio is N/A. In terms of profitability, ISPC's ROE is -5.85%, compared to BIAFW's ROE of -3.59%. Regarding short-term risk, ISPC is more volatile compared to BIAFW. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check BIAFW's competition here
ISPC vs BIOC Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, ISPC is priced at $3.16, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas BIOC's P/E ratio is -0.01. In terms of profitability, ISPC's ROE is -5.85%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, ISPC is less volatile compared to BIOC. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check BIOC's competition here
ISPC vs PRENW Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, PRENW has a market cap of 202.3K. Regarding current trading prices, ISPC is priced at $3.16, while PRENW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas PRENW's P/E ratio is N/A. In terms of profitability, ISPC's ROE is -5.85%, compared to PRENW's ROE of -0.36%. Regarding short-term risk, ISPC is less volatile compared to PRENW. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check PRENW's competition here
ISPC vs SQLLW Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, SQLLW has a market cap of 164.5K. Regarding current trading prices, ISPC is priced at $3.16, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas SQLLW's P/E ratio is -0.01. In terms of profitability, ISPC's ROE is -5.85%, compared to SQLLW's ROE of +2.74%. Regarding short-term risk, ISPC is less volatile compared to SQLLW. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check SQLLW's competition here
ISPC vs TTOO Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, TTOO has a market cap of 11.2K. Regarding current trading prices, ISPC is priced at $3.16, while TTOO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas TTOO's P/E ratio is -0.01. In terms of profitability, ISPC's ROE is -5.85%, compared to TTOO's ROE of +1.47%. Regarding short-term risk, ISPC is more volatile compared to TTOO. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check TTOO's competition here
ISPC vs PRXL Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, PRXL has a market cap of 0. Regarding current trading prices, ISPC is priced at $3.16, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas PRXL's P/E ratio is N/A. In terms of profitability, ISPC's ROE is -5.85%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, ISPC is more volatile compared to PRXL. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check PRXL's competition here
ISPC vs OCDX Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, OCDX has a market cap of 0. Regarding current trading prices, ISPC is priced at $3.16, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas OCDX's P/E ratio is -42.28. In terms of profitability, ISPC's ROE is -5.85%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, ISPC is more volatile compared to OCDX. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check OCDX's competition here
ISPC vs DHR-PA Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, ISPC is priced at $3.16, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, ISPC's ROE is -5.85%, compared to DHR-PA's ROE of +0.07%. Regarding short-term risk, ISPC is more volatile compared to DHR-PA. This indicates potentially higher risk in terms of short-term price fluctuations for ISPC.Check DHR-PA's competition here
ISPC vs CHEKZ Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, ISPC is priced at $3.16, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, ISPC's ROE is -5.85%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, ISPC is less volatile compared to CHEKZ. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check CHEKZ's competition here
ISPC vs NDRAW Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, ISPC is priced at $3.16, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas NDRAW's P/E ratio is N/A. In terms of profitability, ISPC's ROE is -5.85%, compared to NDRAW's ROE of -5.13%. Regarding short-term risk, ISPC is less volatile compared to NDRAW. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check NDRAW's competition here
ISPC vs BNGOW Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, ISPC is priced at $3.16, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas BNGOW's P/E ratio is N/A. In terms of profitability, ISPC's ROE is -5.85%, compared to BNGOW's ROE of -0.71%. Regarding short-term risk, ISPC is less volatile compared to BNGOW. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check BNGOW's competition here
ISPC vs MEUSW Comparison June 2026
ISPC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ISPC stands at 438.8K. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, ISPC is priced at $3.16, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ISPC currently has a P/E ratio of -0.01, whereas MEUSW's P/E ratio is N/A. In terms of profitability, ISPC's ROE is -5.85%, compared to MEUSW's ROE of -7.71%. Regarding short-term risk, ISPC is less volatile compared to MEUSW. This indicates potentially lower risk in terms of short-term price fluctuations for ISPC.Check MEUSW's competition here